Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Endocrinology
•
Adrenal Disorders
Does Entresto interfere with the measurement of ARR (Aldosterone to Renin Ratio) when working up a patient for hyperaldosteronism?
Related Questions
Would you recommend testing for adrenal dysfunction in a euvolemic and hypertensive patient on anti-hypertensive therapy presenting with combined hyperkalemia and hyponatremia?
Would you expect an oral sodium loading test to be positive in secondary hyperaldosteronism or pseudohyperaldosteronism?
Do patients with central adrenal insufficiency on maintenance hydrocortisone therapy require doubling of their corticosteroid during chemotherapy cycles?
Do you recommend combined baseline cortisol and DHEA-S testing to improve the efficiency and accuracy of adrenal insufficiency diagnosis?
Can 24-hour urine aldosterone levels be used to screen for primary aldosteronism in a patient taking finerenone?
What 60 minute cortisol threshold value do you use for diagnosis of adrenal insufficiency after ACTH stimulation?
Do progesterone only oral contraceptive pills affect cortisol binding globulin?
When performing adrenal vein sampling, is calculating selectivity index using androstenedione superior to using cortisol alone for determining successful catheterization?
Do you interpret failure to develop hypernatremia with prolonged water deprivation (such as for 12 hours) as evidence against diabetes insipidus even if the urine osmolality is just below normal?
Is there a role for monitoring PTH levels in patients with advanced chronic kidney disease who are receiving denosumab to assess for adynamic bone disease?